BioNTech
Highly Engaged Employees
Business Services · Germany · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
An Der Goldgrube 12, Mainz, Rheinland-Pf...Phone Number
+49613190840Website
www.biontech.comRevenue
$3.2 BillionStock Symbol
BNTXIndustry
About BioNTech
BioNTech Org Chart
Is BioNTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BioNTech recently announced quarterly report
Check if BioNTech has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if BioNTech had a recent Job posting/layoffs
BioNTech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once BioNTech has new funding data
Product Launch: Get notified when BioNTech launches new products
Congratulate Masked Content for being promoted to Masked Content at BioNTech
Check out if BioNTech is spiking on competitors!
Recommended Actions
Find VP level buyers at BioNTech
Find more new buyers
BioNTech financials insights
Gather financial insights about BioNTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$270M
Series B
$325M
Other Financing Round
$55.7M
Multiple Rounds
$694.8M
BioNTech Tech Stack
A closer look at the technologies used by BioNTech
Most Recent Scoops
BioNTech News & Media
BioNTech (BNTX) Rallied on Moderna’s Win. Does a Competitor’s Success Validate its Oncology Pipeline?
BioNTech SE (NASDAQ:BNTX) rallied following the first positive interim Phase 3 topline result for a personalized mRNA cancer therapy. Moderna and Merck said intismeran, combined with Keytruda, significantly improved recurrence-free and distant metastasis-free survival in patients with surgically removed high-risk melanoma. The result lifted other mRNA developers because it provided the strongest evidence yet that […]Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
NEW YORK and MAINZ, GERMANY, August 27, 2026 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the companies’ 2026-2027 COVID-19 vaccine formula targeting the XFG variant (COMIRNATY® XFG; COVID-19 Vaccine, mRNA) for use in adults ages 65 years and older, as well as in individuals ages 5 through 64 years with atModerna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?
Moderna just posted an 11% surge with zero news behind it, while its longtime mRNA peer BioNTech can barely keep pace with the broader biotech sector. Something broke between these two names, and figuring out what it means for your position is more urgent than it looks.Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips
Moderna just handed back 7% of its staggering year-to-date run in a single session, and the question rattling traders is whether this is a routine exhale or the beginning of a painful unwind for latecomers.
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioNTech
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases... Read More